- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05100147
Uterine Closure Techniques and Cesarean Scar Defect Risk
Comparison of Uterine Closure Techniques During Cesarean Section With Respect to the Development of Cesarean Scar Defects a Randomized Trial.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patients were randomized into three groups using a computer-based program (ratio 1:1:1), and the assigned surgical technique was disclosed just before surgery. At the time of surgery, the sealed opaque envelope, numbered consecutively and containing the description of the suturation technique, was given to the operator. Suturing techniques varied between groups: double layer continuous, non-locking suturing with endometrial inclusion, second layer imbricating the first layer (Group 1), double layer, continuous, non-locking suturing without endometrial inclusion second layer imbricating the first layer (Group 2) and double layer continuous with the first layer unlocked, including the endometrium and the deep part of the myometrium, and the second layer continuous unlocked including the remaining part of the myometrium (Group 3) (Figure 2). Size 1 polyglycolic acid 910 (Vicryl ® Ethicon Inc. Somerville, NJ) was used as suture material in all groups.
Patients were re-evaluated at the sixth month as uterine scar healing is reported to be completed within six months and preoperative assessments were repeated. Transvaginal ultrasonography was performed by an investigator blinded to suturing techniques. Measurements included RMT, and CSD assessment (as the primary outcomes) (including the depth and width of the CSD), as well as other routine ultrasonographic evaluations. Transvaginal sonography was performed by the same investigator with a Toshiba Applio 500 device using a PMW-621VT 6 Mhz R13 probe. CSD was considered when myometrial continuity in the previous caesarean incision site was lost, and an anechoic defective area towards the myometrium was noted. In patients who did not develop CSD, the incision line was measured anteriorly, and the symmetrical posterior uterine wall thickness was measured. In patients with CSD, the myometrium tissue above the anechoic defective area was evaluated as residual myometrial thickness. The CSD sac's depth and its base's width were measured. The full-thickness myometrium adjacent to the defect area was measured, and recovery rates were calculated by taking the percentage of the residual myometrial thickness over the defect to the full-thickness myometrium.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Mersin, Turkey, 33170
- Mersin University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- being nulliparous
- having singleton fetus
- not having diabetes and or hypertension
- not having an intrauterine infection
- body mass index <35 kg/m2
- not having any placental insertion anomalies
- not having Mullerian anomalies
- active phase of labor is not started.
- no previous uterine surgeries
Exclusion Criteria:
- being multiparous
- having multiple pregnancies
- having diabetes and or hypertension
- having an intrauterine infection
- body mass index >=35 kg/m2
- having any placental insertion anomalies
- having Mullerian anomalies
- in active phase of labor
- having previous uterine surgeries
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group 1
The uterotomy suture technique is continous, double layer suturing, in which the first layer is continuous and unlocked involving all uterine layers and a second, continuous non-locking imbrictating layer is applied over the first suture.
|
The uterotomy is sutured after the delivery of the fetus and the placenta with an appropriate delayed absorbable suture (number 1 polyglactin 910)
|
|
Experimental: Group 2
The uterotomy suture technique is continous, double layer suturing, in which the first layer is continuous and unlocked not including decidua and a second, continuous non-locking imbrictating layer is applied over the first suture.
|
The uterotomy is sutured after the delivery of the fetus and the placenta with an appropriate delayed absorbable suture (number 1 polyglactin 910)
|
|
Experimental: Group 3
The uterotomy suture technique is continous ,double layer with the first layer unlocked, excluding the decidua and including the deep part of the myometrium, and the second layer unlocked including the remaining part of the myometrium.
|
The uterotomy is sutured after the delivery of the fetus and the placenta with an appropriate delayed absorbable suture (number 1 polyglactin 910)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Scar thickness at postpartum 6th week
Time Frame: Postpartum 6th weeks
|
The patients will be examined at the postpartum sixth week.
During that visit uterine scar thickness will be measured by ultrasound.
Measurement of uterine scar thickness will be performed perpendicular to the uterine wall and calipers will be placed on the serosal surface of the uterus and the delineation of the endometrium.
These landmarks represent the inner and outer edge of the Cesarean scar.
|
Postpartum 6th weeks
|
|
Scar thickness at postpartum 6th month
Time Frame: Postpartum 6th months
|
The patients will be reexamined at the postpartum sixth month.
During that visit uterine scar thickness will be measured again.
Measurement of uterine scar thickness will be performed with the same method (perpendicular to the uterine wall and calipers will be placed on the serosal surface of the uterus and the delineation of the endometrium.
These landmarks represent the inner and outer edge of the Cesarean scar.)
|
Postpartum 6th months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Ezgi Oktay, MD, Mersin University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 473
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cesarean Section Complications
-
Assiut UniversityNot yet recruitingCesarean Section Complications | Cesarean Section Niche
-
Recep Tayyip Erdogan University Training and Research...CompletedCesarean Section Complications | Cesarean Section; DehiscenceTurkey
-
Ataturk UniversityUnknownCesarean Section Complications | Cesarean Section; Complications, Wound, Dehiscence | Cesarean Section, Repeated | Cesarean, Uterine Scar Thickness | Cesarean, Residual Myometrial ThicknessTurkey
-
Odense University HospitalHvidovre University Hospital; Smith & Nephew, Inc.; University of Southern Denmark and other collaboratorsCompletedSurgical Wound Infection | Cesarean Section; Dehiscence | Complications; Cesarean Section | Infection; Cesarean Section | Complications; Cesarean Section, Wound, Dehiscence | Wound; Rupture, Surgery, Cesarean SectionDenmark
-
Aswan UniversityNot yet recruiting
-
Sygehus LillebaeltUniversity of Southern Denmark, Department of Regional Health ResearchRecruiting
-
Cairo UniversityCompletedCesarean Section ComplicationsEgypt
-
Duke UniversityCompleted
-
Kanuni Sultan Suleyman Training and Research HospitalCompleted
-
University of FoggiaCasa Sollievo della Sofferenza IRCCSActive, not recruitingCesarean Section ComplicationsItaly
Clinical Trials on Uterine closure during Cesarean section
-
Medical University of ViennaUnknownCesarean Section | Transvaginal Ultrasound | Uterine Scar Deficiency | Myometrial Thickness | Single-layer Continuous Uterotomy Suture | Double-layer Continuous Uterotomy SutureAustria
-
Adana City Training and Research HospitalCompletedPain | Cesarean Section | Cosmetics SensitivityTurkey
-
Hédi Chaker HospitalCompletedPelvic Pain | Metrorrhagia | Amenorrhea Secondary | Spotting | Cesarean Scar Defect (Isthmococele)Tunisia
-
Istanbul University - Cerrahpasa (IUC)CompletedCesarean Section Complications | Postpartum HemorrhageTurkey
-
Benha UniversityCompletedCesarean Section Complications | Scarred Uterus | Scar NicheEgypt
-
Cairo UniversityUnknownCesarean Section ScarEgypt
-
Cairo UniversityUnknown
-
Cairo UniversityCompletedIntrauterine Contraceptive Device ComplicationEgypt
-
Mountain Area Health Organization CenterUnknown
-
Lucie Medical IncCompletedCesarean Delivery ProceduresUnited States